Leading the Way in Life Science Technologies

GEN Exclusives

More »

The Lists

More »

For full access to this article login to GEN Select now.

Jan 22, 2013

10 Predictions That Will Transform Healthcare

Peer into GEN's crystal ball for a glimpse of what's to come.

10 Predictions That Will Transform Healthcare

Check out the trends we think are likely to reshape biopharma in the coming years. [© Jérôme SALORT - Fotolia.com]

  • With all the new developments taking place in biopharma right now, it often feels like we’re living in the future—but the future holds even ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.
    •  


Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »